(5,6-Dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-phenyl-amine

ID: ALA75049

Chembl Id: CHEMBL75049

PubChem CID: 13492269

Max Phase: Preclinical

Molecular Formula: C14H14N4

Molecular Weight: 238.29

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cc1[nH]c2ncnc(Nc3ccccc3)c2c1C

Standard InChI:  InChI=1S/C14H14N4/c1-9-10(2)17-13-12(9)14(16-8-15-13)18-11-6-4-3-5-7-11/h3-8H,1-2H3,(H2,15,16,17,18)

Standard InChI Key:  CGSZHEPJBCJZLG-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA75049

   (5,6-Dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-phenyl-amine

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 238.29

Molecular Weight (Monoisotopic): 238.1218

AlogP: 3.32

#Rotatable Bonds: 2

Polar Surface Area: 53.60

Molecular Species: NEUTRAL

HBA: 3

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 5.39

CX LogP: 3.26

CX LogD: 3.26

Aromatic Rings: 3

Heavy Atoms: 18

QED Weighted: 0.72

Np Likeness Score: -1.07

References

1. Traxler PM, Furet P, Mett H, Buchdunger E, Meyer T, Lydon N..  (1996)  4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase.,  39  (12): [PMID:8691423] [10.1021/jm960118j]

Source

Source(1):

• Scientific Literature